Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Reports: Roche | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Reports: Roche

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Roche 1Q13

1Q Revenues: $12.5 billion (+4%)

1Q Earnings: not disclosed

Comments: Pharma revenues overall rose 5% to $9.9 billion, with U.S. sales up 13% to $4.2 billion, European sales up 1% to $2.5 billion, Japanese sales down 12% to $888 million, and rest-of-world sales up 6% to $2.3 billion. Rituxan sales were up 6% to $1.8 billion; Herceptin sales rose 11% to $1.7 billion and Avastin sales climbed 11% to $1.6 billion. Tamiflu sales were up 84% to $360 million in the quarter, and Actemra climbed 32% to $256 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters